Abstract
Infected aortic endografts and mycotic aneurysms are a significant source of morbidity and mortality. Many patients are not suitable for open repair with endograft explant and aortic reconstruction. Advances in endovascular approaches with standardization of antibiotic soaking protocols may provide a palliative treatment option for patients at prohibitive risk for open surgery. Here, we describe the treatment of a rapidly expanding symptomatic infected aortic aneurysm with in situ laser fenestrated endovascular aneurysm repair using a rifampin-soaked endograft and the associated outcome.